A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 3 960,72 Kč, with a 24-hour trading volume of 7,19B Kč. The asset's market cap is 6,14T Kč, after moving -1.18% in the last day.
Tokenized AstraZeneca PLC is trading at 1 972,48 Kč, with a tokenized market cap of 270,2M Kč and a 24-hour trading volume of 16,62M Kč. The tokenized asset has moved -1.98% in the past 24 hours.